Atlas Trials

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

Clinical trial NCT04065438 · RECRUITING

Trial details

NCT number
NCT04065438
Sponsor
Kaneka Medical America LLC
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Focal Segmental Glomerulosclerosis
Start date
2020-01-01
Primary completion
2026-04-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.